All Blogs

Nov 04, 2020

Bristol Myers' Experimental Psoriasis drug succeeds in late-stage study defeats rival Amgen's Otezla Bristol Myers' experimental psoriasis drug, deucravacitinib has outmarched Amgen's Otezla (apremilast) in the POETYK PSO-1 Phase III clinical trial in patients with moderate to severe plaque psoriasis. Deucravaci...

Nov 03, 2020

The United States of America is undergoing the 59th quadrennial presidential election. Since the founding of the nation, the political system in the US is majorly dominated by two parties- the Democratic and the Republican party. After various campaigns and two rounds of debates between the leading presidential can...

Nov 02, 2020

Epidermolysis bullosa (EB) places a significant socioeconomic burden on patients. Several reports stated that Epidermolysis bullosa had a considerable negative impact on the quality of the lives of patients. Although it is a rare disease, EB is a cause of significant morbidity and mortality among the affected indiv...

Oct 30, 2020

Everyone can think that extra add-ons to the living may change the lifestyles. Is the leverage similar in life with an extra-chromosome?? The answer is, No! Take the case of Down syndrome (DS) that has an extra copy of chromosome 21 and associated higher societal costs with physical changes and intellectual disa...

Oct 29, 2020

Novartis taps Molecular Partners for a novel approach to combat COVID-19 Novartis is spending USD 69 million upfront on a pair of experimental drugs from Molecular Partners. The pact is for MP0420 and MP0423, two antivirals out of the biotech’s so-called DARPin tech, which Molecular Partners says that it has ...

Oct 28, 2020

Artificial intelligence (AI) is the talk of the town. Though the term AI and its uses are not new, however, in the past few years there has been a phenomenal growth in AI research and its applications. Today, AI is making its way in almost every sector. Feeding on a large amount of data, AI can mimic human-like tas...

Oct 27, 2020

Bayer Set to Fork Over USD 4 Billion for AskBio’s Gene Therapies Germany-based Bayer is set to acquire North Carolina-based Asklepios BioPharmaceutical (AskBio) with motives to get its hands on its gene therapies.  Bayer will pay USD 2 billion in upfront payment in exchange for AskBio's AAV-based gene th...

Aug 13, 2024

Every year during Breast Cancer Awareness Month, numerous campaigns aim to raise awareness about breast cancer, its symptoms, early diagnosis, and treatment options. Significant progress has been made in managing breast cancer, assessing its risks, and treating it through a combination of surgery, radiation, and ot...

Aug 08, 2024

October, a month awash in pink, stands as a global testament to Breast Cancer Awareness Month. Pink ribbons flutter in the breeze, pink tee-shirts fill the streets, and pink banners drape buildings. This vibrant display of pink is more than a color; it’s a unified call to action, dedicating a month to raising aware...

Oct 22, 2020

GSK eyes robust immune response from RSV vaccine  Cold viruses mostly do not get much attention in terms of R&D. They usually make humans feel miserable for a few days, and later than clear up. However, some cold viruses can hit vulnerable people much harder, which leads to pneumonia and hospitalizations. Th...